Osprey Private Wealth LLC Raises Stake in Danaher Corporation $DHR

Osprey Private Wealth LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 37.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 21,105 shares of the conglomerate’s stock after buying an additional 5,730 shares during the quarter. Danaher accounts for 1.4% of Osprey Private Wealth LLC’s investment portfolio, making the stock its 28th largest holding. Osprey Private Wealth LLC’s holdings in Danaher were worth $4,831,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Income Insurance Ltd bought a new position in Danaher in the 4th quarter worth about $440,000. Advisor OS LLC increased its stake in Danaher by 2.0% in the 4th quarter. Advisor OS LLC now owns 6,103 shares of the conglomerate’s stock worth $1,397,000 after acquiring an additional 118 shares during the last quarter. Nan Fung Trinity HK Ltd. increased its stake in Danaher by 66.8% in the 4th quarter. Nan Fung Trinity HK Ltd. now owns 98,600 shares of the conglomerate’s stock worth $22,572,000 after acquiring an additional 39,500 shares during the last quarter. Midwest Trust Co increased its stake in Danaher by 1.1% in the 4th quarter. Midwest Trust Co now owns 122,005 shares of the conglomerate’s stock worth $27,929,000 after acquiring an additional 1,335 shares during the last quarter. Finally, Oxbow Advisors LLC bought a new position in Danaher in the 4th quarter worth about $203,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $170.98 on Friday. The business’s 50-day moving average price is $191.25 and its 200-day moving average price is $212.54. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $170.74 and a 12 month high of $242.80. The firm has a market capitalization of $121.01 billion, a PE ratio of 33.07, a price-to-earnings-growth ratio of 2.29 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the company earned $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. Sell-side analysts forecast that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on DHR shares. JPMorgan Chase & Co. decreased their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. UBS Group reduced their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. The Goldman Sachs Group reduced their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, Guggenheim reduced their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $240.70.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.